Hormone replacement therapy and cardioprotection in the elderly

Rich-Edwards J.W. , Manson J.E. , Hcnnckcns C.H. , Buring J.E. The primary prevention of coronary heart disease in women. N Engl J Med 1995; 332: 1758–66.

Grodstein F. , Stampfer M.J. , Manson J.E. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–61.

Collins P. , Rosano G.M.C. , Sarrel P.M. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24–30.

Kawano H. , Motoyama T. , Kugivama K. Gender difference in improvement of endothelial-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol 1997; 30: 914–19.

Samaan S.A. , Crawford M.H. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol 1995; 26: 1403–10.

Mijatovic V. , Pines A. , Stehouwer C.D. A. , van der Mooren M.J. , Kenemans P. The effects of oestrogen on vessel wall and cardiac function, haemostasis and homocysteine metabolism. Eur Menopause J 1996; 3: 209–18.

Pines A. , Mijatovic V. , van der Mooren M.J. , Kenemans P. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynecol Rep Biol 1997; 71: 193–7.

Wren G.B. Blood pressure. Effects of estrogen and management of hypertension in women. In: Lobo R.A. , ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven, 1994: 283–5.

The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273: 199–208.

Alfie J. , Lugones L. , Belardo A. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. Maturitas 1997; 27: 163–9.

van der Mooren M.J. Reduced blood pressure in hypertensive women on combined oestradiol/dydrogesterone therapy [Abstract]. Acta Obstet Gynecol Scand 1997; 76(suppl 167: 5): 59.

European Consensus Development Conference on Menopause. Cardiovascular disease and menopause. Participants: Vessey M, Stampfer M, Breart G, Godsland I, Pines A, Samsioe G, Sullivan J. Hum Reprod 1996; 11: 975–9.

American College of Physicians. Guidelines for counselling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992; 117: 1038–41.

Mosca L. , Manson J.E. , Sutherland S.E. , Langer R.D. , Naolio T. , Barrett-Connor E. Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 1997; 96: 2468–82.

Handa V.L. , Landerman R.L. , Hanlon J.T. , Harris T. , Cohen H.J. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996; 44: 1–6.

Ettinger B. , Quesenberry C. , Schroeder D.A. , Friedman G. Long-term postmenopausal estrogen therapy may be associated with increased risk of breast cancer: a cohort study. Menopause 1997; 4: 125–9.

Salamone L.M. , Pressman A.R. , Seeley D.G. , Cauley J.A. Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med 1996; 156: 1293–7.

Miller K.I. Hormone replacement therapy in the elderly. Clin Obstet Gynecol 1996; 39: 912–32.

Ettinger B. , Friedman G.D. , Bush T. , Quesenberry C.P. Jr. Decreased mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996; 87: 6–12.

Sidney S. , Petitti D.B. , Quesenberry C.P. Jr. Myocardial infarction and the use of estrogen and estrogen–progestogen in postmenopausal women. Ann Intern Med 1997; 127: 501–8.

Psaty B.M. , Heckbert S.R. , Atkins D. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 1994; 154: 1333–9.

Henderson B.E. , Paganini-Hill A. , Ross R.K. Reduced mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151: 75–8.

Bush T.L. , Barrett-Connor E. , Cowan L.D. Cardiovascular mortality and noncontraceptive use of estrogen in women. Results from the Lipid Research Clinics Program Follow Up Study. Circulation 1987; 75: 1102–9.

Falkeborne M. , Persson I. , Adami H-O , Bergstrom R. , Eaker E. , Lithell H. , Mohsen R. , Naessen T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992; 99: 821–8.

Folsom A.R. , Mink P.J. , Sellers T.A. , Hong C.P. , Zheng W. , Potter J.D. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Publ Health 1995; 85: 1128–32.

Manolio T.A. , Furberg C.D. , Shemanski U. Association of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 1993; 88[part 1]: 2163–71.

White M.M. , Zamudio S. , Stevens T. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 1995; 6: 739–51.

Gruchow H.W. , Anderson A.J. , Barboriak J.J. , Sobocinsky K.A. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115: 954–63.

Hong M.K. , Romm P.A. , Reagen K. , Green C.E. , Rackley C.E. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992; 69: 176–8.

Newton K.M. , LaCroix A.Z. , McKnight B. Estrogen replacement therapy and prognosis after first myocardial infarction. Am J Epidemiol 1997; 145: 269–77.

Sullivan J. , Vander Zwaag R. , Hughes J.P. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 1990; 150: 2557–62.

Sullivan J.M. , El-Zeky F. , Vander Zwaag R. , Ramanathan K.B. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 1997; 79: 847–50.

O'Keefe J.H. , Kim S.C. , Hall R.R. , Cochran V.C. , Lawhorn S.L. , McCallister B.D. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997; 29: 1–5.